We have assembled an outstanding group of individuals who come from across the country to serve as an External Advisory Board for the BCMB department.
The purpose of the board is to provide input on our departmental mission and goals and to give feedback on a variety of issues regarding our curriculum, our preparation of students for future careers, the research activities in the department, and our outreach activities.
Donald L. Akers Jr., MD, FACS is a practicing vascular and general surgeon in Knoxville, TN. After graduating from UT-Knoxville, he obtained his MD from the University of Tennessee Health Science Center in Memphis. He pursued his residency in General Surgery from Tulane University in New Orleans. His fellowships were in Vascular Surgery at the University of Cincinnati and in Endovascular Surgery at the UT Medical Center in Knoxville. Dr. Akers is Board Certified by the American Board of Surgery in General Surgery and Vascular Surgery. He is a Fellow with the American College of Surgeons. He joined Premier Surgical Associates following extended service as a Professor in the Department of Surgery at Tulane University from 1991-2007.
William G. Beasley, BS, CCRP is the vice president of Clinical Research at BioMimetic Therapeutics, Inc., located in Franklin, Tennessee. He received a bachelor’s in biology (cum laude) from UT. Beasley led the orthopedic program resulting in the Device License Application (DLA) approval in Canada and pending pre-market application (PMA) review for recombinant growth factor for foot and ankle fusion applications. In addition, he directed the clinical operations for the company’s lead therapeutic application for recombinant platelet-derived growth factor (rhPDGF-BB) approved for dental applications.
Beasley’s clinical trial therapeutic experience includes CNS (Multiple Sclerosis, migraine); dermatology (psoriasis) orthopedics, periodontics, tissue engineered therapeutics, and in vitro diagnostics. He has certifications and memberships in the Certified Clinical Research Professional (CCRP), the Drug Information Association (DIA), the Association of Clinical Research Professionals (ACRP), and the Society of Clinical Research Associates (SoCRA). His awards and honors include Phi Beta Kappa, Golden Key National Honor Society, Phi Eta Sigma Honor Society, and Order of Omega.
Carole Dabney-Smith is an assistant professor for the Department of Chemistry and Biochemistry at Miami University located in Oxford, Ohio. She received her PhD from UT in biochemistry, cellular, and molecular biology in 2001. She has received funding from the Department of Energy Early Career Research Program for “Thylakoid Assembly and Folded Protein Transport” and from the Ohio Plant Biotechnology Consortium Research Initiative for “understanding thylakoid protein transport for improved Ohio crops,” as well as internal funding from the College of Arts and Science Summer Research Grant and the Miami University Committee for Faculty Research for the “Overexpression and Purification of Membrane-Bound Protein Transport Components”. She is a member of the International Society of Photosynthesis Research, American Society of Cell Biology, the American Society of Plant Biologists, and a member of the Midwest-Section American Society of Plant Biologists.
Dabney-Smith received the Science Alliance Graduate Student Award for Research, the Alexander Hollaender Fellowship, Yates Dissertation Fellowship, and the Citation for Extraordinary Professional Promise from UT. She has been an invited presenter for the Department of Chemical Engineering at the University of Cincinnati, also for the thirteenth International Congress on Photosynthesis in Montreal, Canada, and for the Southern-Section American Society of Plant Biologists in Chattanooga, Tennessee.
Mary Kot, professor of biology and former chair of Biology from 2003 until 2010 has been at Mercer University since 1991. She is currently the director of Global Health Systems and was the director of Scientific Inquiry Program at Mercer University from 2002 to 2003. She received her PhD from UT. Her specialty is cell biology and her research interest is the contribution of Candida albicans to biofilm formation. Kot has written a paper, “The Hungry Gene as a Core Text in a Freshman Learning Community” that was included in The Place of Core.
John Lamerdin is currently senior counsel in the Intellectual Property and Litigation group of Amgen, Inc. in Thousand Oaks, California. Previously, he was associate patent counsel and patent counsel in the Patent Department of Bristol-Myers Squibb Co in Princeton, New Jersey. Before practicing as an in-house attorney, Lamerdin was an associate attorney with Jenkins & Wilson, a patent law firm in Durham, North Carolina. Lamerdin earned his PhD in the Department of Biochemistry at UT, working in the lab of Engin Serpersu. Lamerdin also holds a JD from Franklin Pierce Law Center in Concord, New Hampshire, and an MS in chemistry (concentration in biochemistry) from San Francisco State University in California. He completed his undergraduate studies at the University of Redlands in Redlands, California, where he earned a BS in chemistry and a BA in philosophy. He is licensed in various state and federal courts and focuses his practice on biopharmaceutical and biotechnology patent and intellectual property matters.
Dr. Paul T. Naylor is a practicing orthopedic surgeon in Knoxville who specializes in sports medicine, surgery of the shoulder, and total joint replacement. After graduating with his MD from the University of Tennessee Medical Center in Memphis, he pursued his residency at the Wake Forest School of Medicine, North Carolina Baptist Hospital in Winston-Salem, North Carolina. He is certified by the American Board of Orthopaedic Surgery. Before attending medical school, Naylor received his PhD in biochemistry, from UT, where he was a published scientist studying cell biology, musculoskeletal infection, and antibiotic resistance. Naylor is a member of the American Academy of Orthopaedic Surgeons, the Southern Medical Association, the American Medical Association, the Orthopaedic Research Society, and he is Licensed in the States of Tennessee and North Carolina.
Paul Ottaviano has over thirty-five years of executive leadership, entrepreneurial, research, and teaching experience in the healthcare industry. In addition he has taught undergraduate and graduate college level courses, served on the boards of colleges, presidential advisory committees, and lead research efforts at the medical school level. During these thirty-five years he has helped to found two publicly traded companies (International Clinical Laboratories and ClinTrials Research) and two privately held companies (Cytometry Associates and GeneRx-Plus ). Since April of 2008 he has been teaching at the college level in both upper level science and business and participating in various capacities with Emory School of Medicine, Lincoln Memorial University, Maryville College, and Tennessee Wesleyan College.
From July 2001 to April 2008, Ottaviano was president and chief executive officer for several divisions of TEAM HEALTH Inc., including Anesthesia Management, After Hours Pediatrics, and Medical Call Centers/Occupational Health. Team Health is a billion-dollar provider of hospital-based physician services, primarily to emergency departments. He served in the United States Army from 1971 until 1973 when he was honorably discharged. One of his many honors while serving was the National Service Commendation Medal. Ottaviano received his MBA in 1978 from the University of South Carolina and his MS in microbiology from East Tennessee State University.
Dr. Richard Smith earned his MD at the University of Tennessee, Memphis, in 1984. He completed his surgery internship and orthopedic surgery residency at the university hospital in Jacksonville, Florida. He is a Tennessee native, originally from Chattanooga. Smith began his practice in 1990. He is a board-certified orthopedic surgeon and possesses the American Board of Orthopedic Surgeons Certificate of Added Qualification in Surgery of the Hand. His interests are injuries and problems of the hand, wrist, and elbow.
Smith also specializes in the treatment of arthritis, carpal tunnel surgery, and injuries of the upper extremity. Smith currently serves as a clinical instructor in the Department of Surgery as the University of Tennessee Medical Center in Knoxville. His professional distinctions are the Knoxville Academy of Medicine, the Knoxville Orthopedic Society, the Tennessee Orthopedic Society, the Tennessee Medical Association, the American Medical Association, the American Academy of Orthopedic Surgery, and the American Society of Surgery of the Hand.
Sean Michael Sullivan received his PhD in 1984 in biochemistry from UT, followed by postdoctoral training at California Institute of Technology from 1984 until 1987. In 2007 he became the executive director for Pharmaceutical Sciences Vical, Inc. located in San Diego, California. Before this position he was an associate professor in the Department of Pharmaceutics at the University of Florida for seven years.
Sullivan supervised an academic research program that developed cancer gene therapeutics for treatment of brain cancer with target focused on anti-angiogenesis and developed organ culture models for cerebral proliferating arteries and brain tumor slice cultures for screening genes and developing targeted delivery systems. He developed a drug delivery program at Ribozyme Pharmaceuticals (RPI) for the delivery of ribozymes. Both lipid and polymer based delivery vehicles were developed. He also successfully developed an in vivo ocular delivery vehicle at RPI for ribozyme delivery to the corneal epithelial layer of the eye using polyacrylic acid. He is a member of the American Association of Pharmaceutical Science and the America Society for Gene Therapy. He is on the Scientific Advisory Board for Discovery Genomics in Minneapolis.
Jason Grant Williams earned his PhD in biochemistry and biophysics in 2001 at the University of North Carolina at Chapel Hill after graduating from the biochemistry department at UT in 1996. Since 2004 he has been working for the National Institute of Environmental Health Sciences as the director of the Protein Microcharacterization Core Facility (PMCF). He manages both the scientific and administrative operations of the PMCF by overseeing personnel, budget, and scientific projects. Williams also completed his postdoctoral fellowship with NIEHS where he elucidated the antigenic surfaces of HIV p24 using limited proteolysis, chemical modification, and mass spectrometry, and also performed initial experiments into the investigation of the tertiary structures of other proteins using chemical modification and mass spectrometry.
Williams developed a unique method of sample purification, concentration, and introduction into a mass spectrometer for analyses of proteins and peptides. Some of his current memberships are with the Association of Biomolecular Resource Facilities, the American Chemical Society, the American Society for Mass Spectrometry, and the Triangle Mass Spectrometry Discussion Group. He has received a number of awards, one being the NIH/NIEHS Performance Award, which he received in 2007, 2008, twice in 2009, and 2010. He also received awards from the Merit Scholarship and the Andrew Holt Scholarship from UT.